Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 9
Submit an article Journal homepage
99
Views
12
CrossRef citations to date
0
Altmetric
Original article: Clinical

Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma

Jatin Shah Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA
,
Wenquan Wang Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA
,
V. Douglas Harrough Biogen Idec, San Diego, CA, USA
,
Wayne Saville Biogen Idec, San Diego, CA, USA
,
Ruby Meredith Department of Radiation Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA
,
Sui Shen Department of Radiation Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA
,
John Mueh Kaiser Permanente, Honolulu, HI, USA
,
John Lister Western Pennsylvania Cancer Institute, Pittsburgh, PA, USA
,
Sri Jasthy Western Pennsylvania Cancer Institute, Pittsburgh, PA, USA
,
Gregory Maggass Arizona Oncology Services Foundation, Phoenix, AZ, USA
,
Charles McKay Tennessee Oncology, Nashville, TN, USA
,
Richard Krumdieck Lake Norman Hematology Oncology Specialists, Mooresville, NC, USA
,
Morgan Tharp Central Indiana Cancer Center, Indianapolis, IN, USA
,
Christine Winter Hinsdale Hematology
,
Stephanie Gregory Rush University Medical Center, Chicago, IL, USA
,
William Buchholz Buchholz Medical Group, Mountain View, CA, USA
,
Sanjay Awasthi Texas Cancer Center, Arlington, TX, USA
,
Samuel Jacobs University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
,
Harold Chung VCU Medical Centre, Oncology Associates, Medical College of Virginia, Richmond, VA, USA
,
James Egner Carle Cancer Center, Urbana, IL, USA
,
Albert F. Lobuglio Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA
&
Andres Forero Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USACorrespondence[email protected]
 show all
Pages 1736-1744 | Received 19 Mar 2007, Accepted 20 Jun 2007, Published online: 01 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Matthew S McKinney & Anne W Beaven. (2014) Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 45-59.
Read now
Martina Lehnert, Heinz Ludwig & Niklas Zojer. (2009) Update on the rational use of 90Y-ibritumomab tiuxetan in the treatment of follicular lymphoma. OncoTargets and Therapy 2, pages 199-208.
Read now

Articles from other publishers (10)

Mahsa Eskian, MirHojjat Khorasanizadeh, Pier L Zinzani & Nima Rezaei. (2018) Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy 10:8, pages 699-711.
Crossref
Michael Tomblyn. (2012) Radioimmunotherapy for B-Cell Non-Hodgkin Lymphomas. Cancer Control 19:3, pages 196-203.
Crossref
Michael F. Leahy & J. Harvey Turner. (2011) Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients. Blood 117:1, pages 45-52.
Crossref
Robert M. Sharkey, Habibe Karacay & David M. Goldenberg. (2010) Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides. Cancer 116:S4, pages 1134-1145.
Crossref
Umberto Vitolo, Giovanni Barosi, Stefano Fanti, Alessandro M. Gianni, Maurizio Martelli, Mario Petrini, Pier Luigi Zinzani & Sante Tura. (2010) Consensus conference on the use of 90‐yttrium‐ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology. American Journal of Hematology 85:2, pages 147-155.
Crossref
Sui Shen, Andres Forero, Ruby F. Meredith, Jatin J. Shah, Susan J. Knox, Gregory A. Wiseman, Marc E. Usrey & Albert F. LoBuglio. (2010) Impact of Rituximab Treatment on 90 Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma . Journal of Nuclear Medicine 51:1, pages 150-157.
Crossref
Robert M. Sharkey, Oliver W. Press & David M. Goldenberg. (2009) A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy. Blood 113:17, pages 3891-3895.
Crossref
N. Rizzo-Padoin. (2008) Apport de la radio-immunothérapie au traitement des lymphomes. Annales Pharmaceutiques Françaises 66:5-6, pages 300-308.
Crossref
M.J. Bishton, M.F. Leahy, R.J. Hicks, J.H. Turner, A.D. McQuillan & J.F. Seymour. (2008) Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab. Annals of Oncology 19:9, pages 1629-1633.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:2, pages 115-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.